California Public Employees Retirement System’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-55,666
Closed -$1.68M 2951
2021
Q1
$1.68M Sell
55,666
-12,058
-18% -$494K ﹤0.01% 2130
2020
Q4
$3.35M Sell
67,724
-1,300
-2% -$60.1K ﹤0.01% 1674
2020
Q3
$2.65M Buy
69,024
+1,900
+3% +$75.6K ﹤0.01% 1657
2020
Q2
$2.9M Buy
67,124
+16,431
+32% +$621K ﹤0.01% 1561
2020
Q1
$1.32M Buy
50,693
+11,260
+29% +$327K ﹤0.01% 1838
2019
Q4
$1.23M Buy
39,433
+29,670
+304% +$878K ﹤0.01% 2259
2019
Q3
$254K Buy
+9,763
New +$249K ﹤0.01% 2815

Other funds holding YMAB

California Public Employees Retirement System's YMAB Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Y-mAbs Therapeutics (YMAB) in Q2 2021, closing a stake of 55,666 shares — an estimated $1.68M sold.

California Public Employees Retirement System first reported a position in YMAB in Q3 2019 and held it in 7 quarters. The position peaked at $3.35M in Q4 2020. 100 funds tracked by Wall St. Rank hold YMAB as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Y-mAbs Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 55,666 Y-mAbs Therapeutics shares in Q2 2021, an estimated $1.68M.
  • California Public Employees Retirement System first reported a position in Y-mAbs Therapeutics in Q3 2019 and held it in 7 quarters.
  • California Public Employees Retirement System's Y-mAbs Therapeutics position peaked at $3.35M in Q4 2020.
  • 100 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.